In addition, downregulation of CHCHD6 in the hippocampus of APP-based mouse models of AD mice promotes aberrant neuronal cholesterol accumulation, amyloidogenesis, synaptic loss, and neuroinflammation, with compensation for CHCHD6 loss mitigating this pathology. This evidence concerns the gene APP and Alzheimer disease.